Astrazeneca Coverage

U.S. to share 80 million vaccines with globe
President Joe Biden plans on sharing millions more doses of COVID-19 vaccines with other countries. Biden has already committed to sharing 60 million doses of the AstraZeneca vaccine by July 4.

Problems with AstraZeneca vaccine could slow global recovery
AstraZeneca's vaccine is key to ending the global economic slump caused by the coronavirus. But a series of missteps by the drugmaker and new concerns over blood clots risk undermining public confidence in the shot and delaying the recovery.

COVID-19 debacle: 'One mistake after another' triggers scathing criticism of AstraZeneca
After teaming up with Oxford University, AstraZeneca produced a safe and effective COVID-19 vaccine in just nine months, a huge achievement that will help end the pandemic. But a series of missteps along the way has led to scathing criticism from policymakers and health officials.

Duke physician discusses AstraZeneca COVID-19 vaccine
Duke infectious disease specialist Dr. Cameron Wolfe, who worked closely with researchers in an AstraZeneca COVID-19 vaccine trial, discusses the vaccine's efficacy.

AstraZeneca vaccine 100% effective at preventing serious illness
AstraZeneca's COVID-19 vaccine provided strong protection against disease and complete protection against hospitalization and death across all age groups in a late-stage U.S. study, the company announced Monday.

Additional countries suspend use of AstraZeneca COVID-19 vaccine over blood clot concerns
Seven other European nations have suspended its use as well over reports that some people have developed blood clots after being vaccinated.

Updated AstraZeneca COVID-19 vaccine could take months
The Anglo-Swedish drugmaker said that production of a vaccine able to effectively combat new COVID-19 variants could take at least six months.

New COVID-19 vaccines are on the way; what this means for getting the public vaccinated
UNC Infectious Disease Expert Dr. Cynthia Gay says the more vaccines we can get, the better.